Conference Coverage

H&N cancer may be undertreated in women

Publish date: June 6, 2018

 

REPORTING FROM ASCO 2018

SOURCE: Park A et al. ASCO 2018 Abstract LBA6002.

Pages

Recommended Reading

ASCO larynx-preservation guidelines reflect important practice changes
MDedge Hematology and Oncology
New and improved classifiers may sharpen thyroid nodule diagnosis
MDedge Hematology and Oncology
Pembrolizumab plus SBRT shows promise for advanced solid tumors
MDedge Hematology and Oncology
Recurrent head and neck cancer presenting as a large retroperitoneal mass
MDedge Hematology and Oncology
When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
MDedge Hematology and Oncology
Probe linked to smartphone found effective in diagnosing oral cancer
MDedge Hematology and Oncology
Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma
MDedge Hematology and Oncology
FDA approves dabrafenib/trametinib for BRAF-positive anaplastic thyroid cancer
MDedge Hematology and Oncology
New remote monitoring system lessens symptoms in head and neck cancer
MDedge Hematology and Oncology
Head and neck cancers: Women less commonly receive intensive chemo
MDedge Hematology and Oncology

Related Articles